AbbVie stock heads into the next Xetra session at EUR 253.10
Published on 10/17/2026 at 10:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date and trading setup
- AbbVie announced its October 30, 2026 results date on October 1, 2026.
- AbbVie stock last traded at EUR 253.10 on the Xetra listing on October 16, 2026.
- The next Xetra session is scheduled for October 19, 2026.
AbbVie stock heads into the next Xetra session at EUR 253.10, based on the last quoted price for the Xetra listing on October 16, 2026. The price is dated and does not represent a live weekend indication.
The week in figures
The Xetra-listed AbbVie share was last quoted at EUR 253.10 on October 16, 2026. The available quote does not provide a verified weekly high, weekly low or prior-week closing price for a weekly percentage calculation.
Chronology of the week
On October 13, 2026, AbbVie published its plan to report third-quarter 2026 results on October 30, 2026. The company said the results would be released before the market opens, followed by a webcast at 8:00 a.m. Central time. Details are provided in the AbbVie investor-relations release dated October 1, 2026.
Dates of the coming week
The next Xetra session is October 19, 2026. AbbVie’s next scheduled corporate date is October 30, 2026, when the company plans to publish third-quarter 2026 results.
Market context: Market report S&P 500.
The next price is shown from the start of trading by the continuously updated real-time quote of AbbVie stock.
